At Constatixin, we provide comprehensive Pinnacle 21 Validation services to ensure that your SDTM, ADaM, and Define-XML deliverables meet CDISC standards and global regulatory requirements. Pinnacle 21 is the industry-leading validation tool used by pharmaceutical companies and regulatory agencies to verify the quality, consistency, and compliance of clinical trial datasets before submission.Our experienced team performs detailed validation checks to identify data inconsistencies, metadata issues, controlled terminology errors, and compliance gaps. We analyze validation reports, resolve findings, and ensure that all datasets are submission-ready, minimizing regulatory risks and accelerating the review process.By combining extensive CDISC expertise with proven quality assurance practices, Constatixin helps organizations deliver accurate, reliable, and fully compliant clinical data that meets the expectations of regulatory authorities such as the FDA, EMA, and PMDA.